Effect Modification of Long‐Term Air Pollution Exposures and the Risk of Incident Cardiovascular Disease in US Women by Hart, Jaime E. et al.
Effect Modification of Long#
Term Air Pollution Exposures
and the Risk of Incident
Cardiovascular Disease in US Women
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Hart, Jaime E., Robin C. Puett, Kathryn M. Rexrode, Christine
M. Albert, and Francine Laden. 2015. “Effect Modification of
Long#Term Air Pollution Exposures and the Risk of Incident
Cardiovascular Disease in US Women.” Journal of the American
Heart Association: Cardiovascular and Cerebrovascular
Disease 4 (12): e002301. doi:10.1161/JAHA.115.002301. http://
dx.doi.org/10.1161/JAHA.115.002301.
Published Version doi:10.1161/JAHA.115.002301
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:26860279
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Effect Modiﬁcation of Long-Term Air Pollution Exposures and the Risk
of Incident Cardiovascular Disease in US Women
Jaime E. Hart, ScD; Robin C. Puett, PhD; Kathryn M. Rexrode, MD, MPH; Christine M. Albert, MD, MPH; Francine Laden, ScD
Background-—Ambient air pollution exposures have been frequently linked to cardiovascular disease (CVD) morbidity and
mortality. However, less is known about the populations most susceptible to these adverse effects.
Methods and Results-—We assessed the associations of long-term particulate matter (PM) exposures with incident CVD in a
nationwide cohort of 114 537 women in the Nurses’ Health Study, and performed analyses to identify subpopulations at the
greatest risk. Residential address level time-varying monthly exposures to PM2.5, PM10, and PM2.5 to 10 microns in diameter were
estimated from spatio-temporal prediction models. In multivariable models, increases in all size fractions of PM were associated
with small, but not statistically signiﬁcant, increased risks of total CVD, coronary heart disease, and stroke. PM-associated CVD
risks were statistically signiﬁcantly higher among women with diabetes as compared to those without (P-for-interaction <0.0001
for PM10 and PM2.5 and 0.007 for PM2.5 to 10). For each 10 lg/m
3 increase in 12-month average PM2.5, PM2.5 to 10, and PM10, the
multivariable adjusted hazard ratios were 1.44 (95% CI: 1.23 to 1.68), 1.17 (95% CI: 1.05 to 1.30), and 1.19 (95% CI: 1.10 to 1.28)
among women with diabetes. There were also suggestions of higher risks among older (≥70 years) women, the obese, and those
living in the Northeast and South. Smoking status and family history did not consistently modify the association between PM and
CVD, and risks were most elevated with exposures in the previous 12 months.
Conclusions-—In this nationwide cohort, women with diabetes were identiﬁed as the subpopulation most sensitive to the adverse
cardiovascular health effects of PM. ( J Am Heart Assoc. 2015;4:e002301 doi: 10.1161/JAHA.115.002301)
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A large body of evidence has formed implicating long-termexposures to particulate matter (PM) air pollution with
an increased risk of cardiovascular disease (CVD) morbidity
and mortality,1,2 leading to the recognition of air pollution as a
major risk factor for these outcomes.3,4 For example, as part
of the Global Burden of Disease 2010 project, ambient
PM exposure was estimated to be responsible for 1.5
million ischemic heart disease deaths in 2010 with
population-attributable fractions of 2% to 41%, depending on
the country.5 In a recent review of the evidence from long-
term studies, each 10 lg/m3 increase in PM <2.5 microns in
aerodynamic diameter (PM2.5) was associated with an 11%
(95% CI: 5 to 16) increased risk of cardiovascular mortality.2
Although the majority of studies have observed elevated risks
with PM exposures, statistically signiﬁcant heterogeneity in
these estimates has been observed, even within studies.6–9
Differences in the prevalence of risk factors and different
proportions of susceptible subpopulations may underlie this
heterogeneity. Therefore, the subpopulations at the greatest
risk remain a key question in the literature.
Among women in the Nurses’ Health Study (NHS) living in
the Northeastern and Midwestern regions of the United
States 1992–2002, we have previously observed an increased
risk of incident overall coronary heart disease (CHD), fatal
CHD, and nonfatal myocardial infarctions (MI) with increasing
long-term exposures to PM2.5, and evidence of heterogeneity
by personal characteristics.10 Our current objectives are to
spatially (to the full contiguous United States) and temporally
(1989–2006) expand our examination of these associations,
to determine whether there is heterogeneity in effect esti-
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mates by region of the country or by personal characteristics
including cardiovascular risk factors, to compare heterogene-
ity in effects across PM size fractions, and to assess the
impact of these exposures on the risk of incident stroke, in
addition to incident CHD.
Methods
Study Population
The NHS is a prospective cohort study of nurses started in
1976. At enrollment, the 121 701 women were 30 to 55 years
of age, married, and completed a mailed questionnaire with
detailed information on demographics, lifestyle characteristics,
and prevalence of a number of diseases. Women were initially
enrolled from a selection of 11 states; however, participants
now live throughout the contiguous United States. Follow-up
questionnaires are mailed every 2 years to update risk factor
and disease status, and response rates have been consistently
over 90%. All residential address locations have been geocoded
to obtain longitude and latitude. Women were included in the
current analyses if they remained alive and free of CVD through
1988, were still responding to questionnaires, and had at least a
single address within the contiguous United States during
1988–2006 where air pollution predictions were available. The
study protocol was approved by the Brigham and Women’s
Hospital Institutional Review Board, and consent was implied
through the return of the questionnaires.
Outcome Assessment
On the baseline and all subsequent follow-up questionnaires,
participants were asked to report all occurrences of physician
diagnosed CVD, speciﬁcally, incidence of CHD or stroke.
Women (or for fatal cases, next-of-kin) were asked to provide
consent to review all medical records pertaining to their
diagnosis. Cases of fatal CHD (ICD-8 and ICD-9 codes 410 to
412, ICD-10 codes I21 to I22) were classiﬁed as deﬁnite if
conﬁrmed by hospital records or through an autopsy, or if
CHD was the most plausible cause of death and there was
prior evidence of CHD. Cases were classiﬁed as probable if
medical records surrounding the death were not available, but
CHD was the underlying cause on the death certiﬁcate,
National Death Index search, or a family member provided
supporting information. Nonfatal MI was classiﬁed as deﬁnite
if the criteria of the World Health Organization were met,
speciﬁcally, symptoms and either electrocardiograph-
detected changes or elevated cardiac-enzyme concentrations.
Cases of nonfatal MIs were designated as probable if an
interview or letter conﬁrming hospitalization for the infarction
was obtained and medical records were unavailable. Overall
incident CHD was determined based on the ﬁrst occurrence of
Table 1. Selected Age-Standardized Characteristics of
Nurses’ Health Study Participants Throughout the Full Period
of Follow-Up (1989–2006) and After 2000
Characteristics,
Mean (SD) or %
Follow-Up Period
1989–2006 2000–2006
N 114 537 96 058
Age, y* 63.5 (8.5) 68.6 (7.3)
Body mass index, kg/m2 25.3 (7.6) 25.6 (7.5)
Body mass index categories
Underweight/normal 43 41
Overweight 32 33
Obese 20 22
Race
White 94 94
Black 2 2
Other/multiple races 6 6
Pack-years of smoking† 24.0 (21.1) 23.6 (21.4)
Smoking status
Never 44 45
Former 42 45
Current 14 11
Menopause status
Premenopausal 8 8
Postmenopausal 86 84
Dubious 5 4
Family history of
myocardial infarction
33 32
Diabetes 8 9
Marital status
Married 63 64
Not married 37 36
Region of residence
Northeast 51 50
Midwest 17 17
West 14 14
South 18 19
Census tract median
income ($1000)
63.9 (25.0) 63.4 (24.3)
Census tract median
home value ($10 000)
17.2 (12.9) 17.2 (12.6)
12-month average exposure*
PM10 22.2 (6.5) 19.3 (5.4)
PM2.5–10 8.7 (4.5) 7.3 (4.1)
PM2.5 13.4 (3.3) 12.0 (2.8)
PM indicates particulate matter.
*Not age standardized.
†Among ever smokers only.
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either nonfatal MI or fatal CHD. Incident strokes were
conﬁrmed if characterized by a typical neurological defect of
sudden or rapid onset, lasting more than 24 hours and
attributable to a cerebrovascular event. Strokes were classi-
ﬁed according to the criteria of the National Survey of Stroke
as due to ischemia (embolic or thrombotic), hemorrhage
Table 2. HRs and 95% CI for a 10 lg/m3 Increase in 12-Month Average PM With Risk of Incident CVD, CHD, or Stroke in the
Nurses’ Health Study
Outcome Cases
Person-
Years
PM10 PM2.5–10 PM2.5
Basic* Multivariable† Basic* Multivariable† Basic* Multivariable†
1989–2006 (N=114 537)
Incident
CVD
6767 1 835 486 1.05 (1.01–1.10)‡ 1.02 (0.97–1.06) 1.11 (1.03–1.19)‡ 1.03 (0.96–1.11) 1.04 (0.96–1.13) 1.02 (0.94–1.10)
Incident
CHD
3878 1 835 486 1.06 (0.99–1.12) 1.01 (0.95–1.07) 1.12 (1.02–1.23)‡ 1.03 (0.93–1.13) 1.02 (0.92–1.14) 0.99 (0.88–1.10)
Incident
stroke
3295 1 835 486 1.05 (0.99–1.12) 1.03 (0.97–1.10) 1.11 (1.00–1.22)‡ 1.05 (0.95–1.16) 1.03 (0.92–1.16) 1.03 (0.92–1.15)
2000–2006 (N=96 058)
Incident
CVD
2413 557 741 1.07 (0.98–1.16) 1.05 (0.96–1.14) 1.07 (0.95–1.21) 1.02 (0.90–1.16) 1.11 (0.96–1.28) 1.11 (0.96–1.29)
Incident
CHD
1301 557 741 1.06 (0.94–1.19) 1.02 (0.91–1.15) 1.08 (0.91–1.28) 1.01 (0.85–1.19) 1.08 (0.88–1.32) 1.05 (0.86–1.29)
Incident
stroke
1194 557 741 1.07 (0.96–1.21) 1.07 (0.95–1.20) 1.07 (0.90–1.27) 1.03 (0.87–1.23) 1.14 (0.93–1.40) 1.18 (0.96–1.45)
BMI indicates body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HRs, hazard ratios; MI, myocardial infarction; PM, particulate matter; SES, socioeconomic status.
*Adjusted for age, time period, region, and season.
†Additionally adjusted for race, smoking status and pack-years, BMI, menopausal status and hormone use, hypercholesterolemia, hypertension, diabetes, family history of MI, and
individual- and area-level SES.
‡P-value <0.05.
Table 3. Pearson Correlations Between All of the Exposure Averaging Periods Considered, 2000–2006
12-Month 24-Month 60-Month 120-Month
PM10 PM2.5–10 PM2.5 PM10 PM2.5–10 PM2.5 PM10 PM2.5–10 PM2.5 PM10 PM2.5–10 PM2.5
12-month
PM10 1.00 0.86 0.67 0.99 0.85 0.67 0.96 0.84 0.65 0.93 0.85 0.61
PM2.5–10 1.00 0.20 0.85 0.99 0.21 0.82 0.97 0.21 0.77 0.93 0.18
PM2.5 1.00 0.65 0.20 0.98 0.65 0.21 0.95 0.67 0.28 0.91
24-month
PM10 1.00 0.86 0.68 0.98 0.86 0.66 0.95 0.87 0.62
PM2.5–10 1.00 0.22 0.84 0.98 0.22 0.78 0.95 0.19
PM2.5 1.00 0.68 0.24 0.97 0.70 0.30 0.93
60-month
PM10 1.00 0.87 0.70 0.98 0.88 0.66
PM2.5–10 1.00 0.24 0.82 0.98 0.21
PM2.5 1.00 0.72 0.30 0.97
120-month
PM10 1.00 0.87 0.72
PM2.5–10 1.00 0.28
PM2.5 1.00
PM indicates particulate matter.
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(subarachnoid hemorrhage or intracerebral hemorrhage), or
unknown cause.11 Nonfatal strokes were designated as
probable when the nurse provided additional information by
interview or letter, but no medical records were available.
Exposure Assessment
Ambient predictions of PM2.5 and PM <10 lm in aerody-
namic diameter (PM10) were available from spatio-temporal
prediction models for all months between January 1988 and
June 2006 for each residential address in the contiguous
United States.12 The models used monthly average PM2.5
and/or PM10 monitoring data from the US Environmental
Protection Agency’s Air Quality System, the IMPROVE
network, and other sources and the addresses were
updated every 2 years.13,14 Generalized additive mixed
models incorporated these measured values with monthly
spatial terms, geospatial predictors (including a number of
potential sources, meteorology, and topology), and terms
for time to create separate PM prediction surfaces for each
month and each PM size fraction.12 Since monitoring data
on PM2.5 were limited prior to 1999, PM2.5 in the period
before 1999 was modeled using data on PM10 and
information on the ratio of PM10 to PM2.5 in each
location.12 PM2.5–10 was calculated by subtraction of the
monthly PM10 and PM2.5 estimates. Cross-validation results
demonstrated that the models had high predictive accuracy
(cross-validation R2 values of 0.59, 0.76, and 0.77
for PM10, pre-1999 PM2.5, and post-1999 PM2.5,
respectively).12
Potential Confounders and Effect Modiﬁers
Information on potential confounders and effect modiﬁers is
available every 2 years (every 4 years for diet information)
from the follow-up questionnaires. Therefore, when appropri-
ate, each woman was assigned updated covariate values for
each questionnaire cycle. We included a number of risk
factors for CVD or predictors of exposure as possible
confounders including: age, race, calendar year, season, body
mass index (BMI; kg/m2), menopausal status and hormone
use, comorbidities (hypertension, hypercholesterolemia, and
type 2 diabetes), and family history of MI. Pack-years of
smoking and current smoking status were calculated for each
time period from information on lifetime smoking history.
Marital status, employment status, and educational attain-
ment of each nurse and, if appropriate, of her spouse/
partner were included as measures of individual-level
socioeconomic status. To control for potential regional
differences in PM composition and/or disease risk, we
controlled for Census region of residence. Census tract level
median income and house value were used to adjust for
area-level socioeconomic status. Each potential confounder
(or set of confounders) was added to a basic model (adjusted
only for age, calendar year, season, and region) 1 at a time
to determine the impact on the effect estimates. All
confounders were included together in a ﬁnal multivariable
model. We considered a number of a priori potential effect
modiﬁers previously suggested in this cohort and in the
wider literature, including region, age, diabetes, family history
of MI, BMI, and smoking status.2,6,8–10,15–17
Statistical Analyses
Person-months of follow-up were calculated from June 1989
through the end of follow-up, incidence of the speciﬁc event
A
B
C
Figure. Multivariable associations for each 10 lg/m3 increase
in time-varying 12-, 24-, 60-, or 120-month particulate matter
exposure with risk of total CVD (A), total CHD (B), or total stroke
(C) 2000–2006. CHD indicates coronary heart disease; CVD,
cardiovascular disease; PM, particulate matter.
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of interest, death, or loss to follow-up, whichever occurred
ﬁrst. Separate time-varying Cox proportional hazards models
were used to assess the association of incident CVD, CHD,
or stroke with 12-month time-varying averages of each size
fraction of PM. Hazard ratios (HRs) and 95% CIs were
calculated for each 10 lg/m3 increase, after assessing the
linearity of each dose-response with cubic regression
splines.18 The dataset was converted to an Anderson–Gill
counting process structure with a record for each month
that included the appropriate person-time, calculated expo-
sure averages, censoring information, and covariates for that
month of follow-up. All models were stratiﬁed by age in
months and month of study to control for age and temporal
effects. To examine effect modiﬁcation, we calculated
stratum-speciﬁc effect estimates and examined the statisti-
cal signiﬁcance of any observed effect modiﬁcation using
likelihood ratio tests. In sensitivity analyses, we performed
all analyses from 2000 forward, to determine whether the
effect estimates were different in the time period where
monitoring data on PM2.5 was directly available for use in
our spatio-temporal prediction models. In the later time
period we also conducted sensitivity analyses to examine
the impact of longer exposure periods (24-, 60-, and
120-month moving averages). An a level of 0.05 was used
to determine statistical signiﬁcance for main effects, and an
a level of 0.0083 (0.05/6 potential modiﬁers) was used for
effect modiﬁers.
Results
Among 114 537 NHS participants eligible for analysis, 6767
women developed CVD during 1 835 486 person-years of
follow-up, and 3878 and 3295 incident cases of CHD and
stroke, respectively, were conﬁrmed during this time. A total
of 96 058 women were available for analyses starting in 2000
(the ﬁrst year PM2.5 was widely monitored), accounting for
2413 incident CVD cases, 1301 incident CHDs, and 1194
incident strokes during 557 741 years of follow-up. Charac-
teristics of the population throughout both follow-up periods
are presented in Table 1. During the full follow-up period,
participants were 63.5 (SD=8.5) years old on average, were
mainly white, married, and postmenopausal, and were never
or former smokers. Characteristics were similar after 2000,
with an average participant age of 68.6 (SD=7.3).
The HRs for each outcome for a 10 lg/m3 increase in
each size fraction of PM are presented in Table 2 for both
Table 4. Multivariable Adjusted HRs and 95% CI for a 10 lg/m3 Increase in 12-Month Average PM 1989–2006 With Risk of
Incident CVD, CHD, or Stroke, Stratiﬁed by Region of Residence
Outcome Cases Person-Years PM10 PM2.5–10 PM2.5
Incident CVD
Northeast 3368 942 058 1.06 (0.98–1.14) 1.16 (1.00–1.34) 1.06 (0.93–1.21)
Midwest 1160 317 068 0.99 (0.89–1.10) 0.99 (0.83–1.18) 0.98 (0.80–1.21)
West 961 254 336 1.01 (0.95–1.07) 1.03 (0.94–1.13) 0.99 (0.87–1.12)
South 1278 322 024 0.95 (0.81–1.11) 0.92 (0.77–1.10) 1.02 (0.83–1.27)
P-for-interaction 0.51 0.22 0.87
Incident CHD
Northeast 1996 942 058 1.03 (0.93–1.14) 1.11 (0.92–1.35) 1.01 (0.85–1.20)
Midwest 659 317 068 1.02 (0.88–1.18) 1.06 (0.84–1.34) 1.00 (0.76–1.31)
West 492 254 336 0.99 (0.91–1.08) 0.99 (0.87–1.13) 0.99 (0.83–1.17)
South 731 322 024 0.97 (0.79–1.20) 1.02 (0.81–1.30) 0.92 (0.69–1.22)
P-for-interaction 0.92 0.79 0.96
Incident stroke
Northeast 1569 942 058 1.06 (0.95–1.19) 1.16 (0.93–1.44) 1.06 (0.87–1.28)
Midwest 576 317 068 0.98 (0.84–1.14) 0.93 (0.72–1.20) 1.03 (0.76–1.38)
West 526 254 336 1.03 (0.95–1.12) 1.09 (0.96–1.23) 0.99 (0.83–1.17)
South 624 322 024 0.97 (0.77–1.22) 0.89 (0.68–1.15) 1.12 (0.83–1.52)
P-for-interaction 0.80 0.27 0.89
Adjusted for age, time period, season, race, smoking status and pack-years, BMI, menopausal status and hormone use, hypercholesterolemia, hypertension, diabetes, family history of MI,
and individual- and area-level SES. BMI indicates body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HRs, hazard ratios; MI, myocardial infarction; PM, particulate
matter; SES, socioeconomic status.
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follow-up periods. In basic models adjusted for age, time
period, region, and season, small increases in the risk of
incident CVD, CHD, and stroke were observed for all size
fractions of PM exposure. These increases only reached
statistical signiﬁcance for the association of PM10 with total
CVD, and for PM2.5–10 with all 3 outcomes in the full period of
follow-up. In multivariable models, the results were generally
attenuated, and none reached statistical signiﬁcance. Individ-
ual and area-level socioeconomic status appeared to be the
most important confounders, and both attenuated the effect
estimates for all size fractions. HRs tended to be more elevated
for PM2.5 in analyses with follow-up starting after 2000, while
for PM2.5 to 10 HRs were higher in the full period of follow-up.
The 12-, 24-, 60-, and 120-month averages were highly
correlated (Table 3) within each size fraction. Within each
averaging period, PM2.5 and PM2.5–10 were weakly correlated
(r0.2), PM2.5 and PM10 were moderately correlated (r0.6),
and PM10 and PM2.5–10 were strongly correlated (r0.8). For
CVD, averaging periods >12 months were associated with
attenuations in risk for each of the size fractions; the HRs for
each 10 lg/m3 increase in PM2.5 were 1.13, 1.08, 1.04, and
1.02 for the 12-, 24-, 60-, and 120-month exposure windows
(Figure). This pattern of attenuations was similar for analyses
of stroke, but was less dramatic for analyses of total CHD.
No statistically signiﬁcant differences in effects were
observed across regions in the full period of follow-up
(Table 4); however, there was a suggestion of effect modiﬁ-
cation by region after 2000 (Table 5), with higher HRs
observed in the Northeast and South. Multivariable models
stratiﬁed by selected cardiovascular risk factors are pre-
sented in Table 6 for the full follow-up period. For all 3
outcomes, HRs were higher among women with diabetes as
compared to those without diabetes, and the test for
interaction was statistically signiﬁcant for the majority of
the end points. Among women with diabetes, during the full
period of follow-up, the HR of incident total CVD for a 10 lg/
m3 increase in PM2.5 was 1.44 (95% CI: 1.23 to 1.68), for
PM2.5–10 was 1.17 (95% CI: 1.05 to 1.30), and for PM10 was
1.19 (95% CI: 1.10 to 1.28). The HRs were higher for stroke
(1.66 [95% CI: 1.31 to 2.10] for PM2.5, 1.18 [95% CI: 1.01 to
1.38] for PM2.5–10, and 1.23 [95% CI: 1.10 to 1.38] for PM10)
than for CHD among these women. Effect modiﬁcation was
not consistently detected for the other effect modiﬁers (age,
family history of MI, BMI, smoking status) across size
Table 5. Multivariable Adjusted HRs and 95% CI for a 10 lg/m3 Increase in 12-Month Average PM 2000–2006 With Risk of
Incident CVD, CHD, or Stroke, Stratiﬁed by Region of Residence
Outcome Cases Person-Years PM10 PM2.5–10 PM2.5
Incident CVD
Northeast 1189 278 905 1.30 (1.10–1.52) 1.47 (1.09–1.99) 1.44 (1.12–1.86)
Midwest 402 93 823 1.00 (0.80–1.25) 0.91 (0.65–1.29) 1.15 (0.74–1.78)
West 335 78 560 0.95 (0.84–1.06) 0.97 (0.81–1.15) 0.85 (0.67–1.07)
South 487 106 454 1.10 (0.82–1.48) 0.93 (0.69–1.24) 1.34 (0.91–1.98)
P-for-interaction 0.02 0.08 0.02
Incident CHD
Northeast 665 278 905 1.29 (1.04–1.60) 1.53 (1.02–2.28) 1.39 (0.99–1.96)
Midwest 212 93 823 1.07 (0.78–1.45) 1.05 (0.66–1.67) 1.17 (0.64–2.15)
West 166 78 560 0.87 (0.73–1.03) 0.88 (0.68–1.13) 0.73 (0.52–1.02)
South 258 106 454 1.07 (0.71–1.61) 0.92 (0.62–1.38) 1.30 (0.76–2.22)
P-for-interaction 0.05 0.15 0.05
Incident stroke
Northeast 568 278 905 1.23 (0.98–1.56) 1.27 (0.81–1.97) 1.42 (0.98–2.05)
Midwest 205 93 823 0.94 (0.68–1.28) 0.78 (0.48–1.27) 1.15 (0.62–2.13)
West 178 78 560 1.03 (0.88–1.20) 1.06 (0.85–1.34) 0.99 (0.73–1.35)
South 243 106 454 1.19 (0.79–1.81) 0.97 (0.64–1.46) 1.44 (0.83–2.50)
P-for-interaction 0.45 0.52 0.44
Adjusted for age, time period, season, race, smoking status and pack-years, BMI, menopausal status and hormone use, hypercholesterolemia, hypertension, diabetes, family history of MI,
and individual- and area-level SES. BMI indicates body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HRs, hazard ratios; MI, myocardial infarction; PM, particulate
matter; SES, socioeconomic status.
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Table 6. Multivariable Adjusted HRs and 95% CI for a 10 lg/m3 Increase in 12-Month Average PM 1989–2006 With Risk of
Incident CVD, CHD, or Stroke, Stratiﬁed by Personal Characteristics
Outcome Cases Person-Years PM10 PM2.5–10 PM2.5
Incident CVD
<70 years old 3429 1 392 830 0.99 (0.93–1.05) 1.00 (0.92–1.09) 0.97 (0.87–1.07)
≥70 years old 3338 442 656 1.06 (1.00–1.13) 1.07 (0.98–1.17) 1.08 (0.97–1.22)
P-for-interaction 0.07 0.17 0.13
Women with diabetes 1512 138 940 1.19 (1.10–1.28)* 1.17 (1.05–1.30)* 1.44 (1.23–1.68)*
Women without diabetes 5255 1 696 546 0.98 (0.94–1.03)* 0.99 (0.93–1.06)* 0.94 (0.86–1.03)*
P-for-interaction <0.0001* 0.007* <0.0001*
Family history 2819 612 206 1.05 (0.99–1.11) 1.06 (0.97–1.15) 1.09 (0.97–1.22)
No family history 3948 1 223 280 1.01 (0.96–1.06) 1.01 (0.94–1.09) 1.00 (0.90–1.10)
P-for-interaction 0.24 0.43 0.23
Underweight/normal 2685 791 374 0.99 (0.93–1.05) 0.98 (0.90–1.06) 0.99 (0.88–1.12)
Overweight 2127 583 357 1.04 (0.97–1.11) 1.05 (0.95–1.15) 1.04 (0.91–1.19)
Obese 1737 376 203 1.09 (1.02–1.18) 1.13 (1.02–1.25) 1.12 (0.97–1.30)
P-for-interaction 0.09 0.10 0.41
Never smokers 2459 803 757 1.01 (0.95–1.07) 1.02 (0.93–1.11) 0.99 (0.88–1.12)
Former smokers 2877 765 086 1.05 (0.99–1.12) 1.06 (0.97–1.15) 1.09 (0.97–1.22)
Current smokers 1422 262 982 1.01 (0.92–1.09) 1.00 (0.89–1.12) 1.00 (0.86–1.17)
P-for-interaction 0.47 0.70 0.47
Incident CHD
<70 years old 2038 1 392 830 0.95 (0.88–1.02)* 0.96 (0.85–1.08) 0.89 (0.77–1.02)
≥70 years old 1840 442 656 1.09 (1.00–1.19)* 1.11 (0.99–1.25) 1.13 (0.97–1.33)
P-for-interaction 0.007* 0.04 0.02
Women with diabetes 1027 138 940 1.12 (1.02–1.23)* 1.14 (1.00–1.30)* 1.20 (0.99–1.46)
Women without diabetes 2851 1 696 546 0.95 (0.89–1.01)* 0.92 (0.84–1.01)* 0.94 (0.84–1.06)
P-for-interaction 0.003* 0.008* 0.03
Family history 1691 612 206 1.04 (0.96–1.12) 1.02 (0.92–1.14) 1.10 (0.95–1.28)
No family history 2187 1 223 280 0.95 (0.89–1.02) 0.94 (0.85–1.04) 0.93 (0.82–1.07)
P-for-interaction 0.09 0.23 0.09
Underweight/normal 1444 791 374 0.95 (0.87–1.03) 0.91 (0.81–1.03) 0.97 (0.82–1.13)
Overweight 1196 583 357 1.01 (0.92–1.11) 1.02 (0.90–1.16) 1.01 (0.84–1.21)
Obese 1078 376 203 1.04 (0.94–1.14) 1.04 (0.91–1.19) 1.08 (0.89–1.30)
P-for-interaction 0.31 0.28 0.68
Never smokers 1309 803 757 1.00 (0.92–1.09) 1.01 (0.90–1.14) 0.97 (0.82–1.14)
Former smokers 1689 765 086 1.00 (0.92–1.08) 0.96 (0.85–1.07) 1.06 (0.91–1.24)
Current smokers 876 262 982 0.97 (0.87–1.08) 0.96 (0.82–1.12) 0.96 (0.78–1.17)
P-for-interaction 0.90 0.77 0.61
Incident stroke
<70 years old 1552 1 392 830 1.02 (0.94–1.11) 1.04 (0.92–1.18) 1.02 (0.88–1.19)
≥70 years old 1743 442 656 1.04 (0.96–1.13) 1.06 (0.94–1.20) 1.04 (0.88–1.21)
P-for-interaction 0.76 0.77 0.89
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fractions. The patterns were similar in post-2000 analyses
(Table 7).
Discussion
In this nationwide prospective study, exposures to PM were
associated with small, but nonstatistically signiﬁcant, eleva-
tions in incident CVD, CHD, and stroke in this cohort of US
women. However, there were consistently statistically signif-
icant elevations in risk for almost all PM size fractions and
outcomes among women with diabetes. There were also
suggestions of effect modiﬁcation by region of residence,
smoking status, obesity, and age, but they were not
consistent across outcomes, size fractions, and time periods.
Overall, we observed larger HRs in models restricted to the
later time periods, especially for PM2.5. This may be due to
effect modiﬁcation by age, as there was a suggestion of
higher HRs among older participants in the full follow-up
period. These ﬁndings may also be due to improvements in
our prediction models after 2000. Reductions in measurement
error in these models would be expected to lead to increases
in the HRs. However, there was overlap in the 95% CIs for the
2 time periods, so it is also possible that our ﬁndings of higher
risks in the later time period are due to chance.
Our multivariable adjusted results in the full cohort for the
full period of follow-up are generally lower than the majority of
studies in the literature, including a previous analysis in the
NHS cohort.10,15,19–28 In models among women in the North-
eastern and Midwestern regions of the United States, we
previously observed multivariable adjusted HRs for CHD
incidence of 1.10 (95% CI: 0.94 to 1.29), 1.11 (95% CI: 0.79
to 1.55), and 1.04 (95% CI: 0.82 to 1.32) for each 10 lg/m3
increase in PM10, PM2.5, and PM2.5–10, respectively.
10,15
However, our ﬁndings for incident CVD in the later time period
are comparable to the equivalent meta-estimate of 10.6% (95%
CI 5.4, 16.0) for CVD and PM2.5 from all studies of long-term
exposures published though January 2013.2 The results of
studies published since then have been more mixed. In the
European Study of Cohorts for Air Pollution Effects (ESCAPE),
each 5 lg/m3 increase in PM2.5 was associated with a
HR=0.99 (95% CI: 0.91 to 1.08) for overall CVD deaths, with
similar ﬁndings for ischemic heart disease and MI deaths, and
for exposures to PM10 and PM2.5–10.
7 They did observe non–
statistically signiﬁcantly increased risks of cerebrovascular
death of20% with all size fractions of PM. In related analyses
of the incidence of acute coronary events, HRs of 1.13 (95% CI:
0.98 to 1.30) per 5 lg/m3 increase in PM2.5, 1.12 (95%CI: 1.01
to 1.25) per 10 lg/m3 increase in PM10, and 1.06 (95%CI: 0.98
to 1.15) per 5 lg/m3 increase in PM2.5–10 were observed.
8 In
an analysis of the American Cancer Society Cancer Prevention
Study II (ACS) cohort, each 10 lg/m3 increase in PM2.5 was
associated with a HR=1.12 (95% CI: 1.10 to 1.15) for CVD
Table 6. Continued
Outcome Cases Person-Years PM10 PM2.5–10 PM2.5
Women with diabetes 659 138 940 1.23 (1.10–1.38)* 1.18 (1.01–1.38) 1.66 (1.31–2.10)*
Women without diabetes 2636 1 696 546 1.03 (0.96–1.09)* 1.08 (0.99–1.18) 0.94 (0.83–1.07)*
P-for-interaction 0.004* 0.33 <0.0001*
Family history 1316 612 206 1.08 (0.99–1.17) 1.13 (1.00–1.26) 1.04 (0.88–1.23)
No family history 1979 1 223 280 1.06 (0.99–1.14) 1.08 (0.98–1.20) 1.06 (0.92–1.22)
P-for-interaction 0.79 0.60 0.83
Underweight/normal 1389 791 374 1.04 (0.96–1.13) 1.07 (0.96–1.20) 1.00 (0.85–1.18)
Overweight 1073 583 357 1.05 (0.95–1.15) 1.06 (0.93–1.21) 1.05 (0.87–1.26)
Obese 772 376 203 1.15 (1.03–1.28) 1.23 (1.06–1.42) 1.15 (0.92–1.43)
P-for-interaction 0.27 0.26 0.61
Never smokers 1266 803 757 1.02 (0.93–1.11) 1.02 (0.91–1.16) 1.02 (0.86–1.21)
Former smokers 1406 765 086 1.11 (1.02–1.21) 1.18 (1.05–1.32) 1.08 (0.91–1.27)
Current smokers 616 262 982 1.05 (0.93–1.18) 1.06 (0.89–1.26) 1.05 (0.83–1.34)
P-for-interaction 0.31 0.20 0.89
Adjusted for age, time period, region, season, race, smoking status and pack-years, BMI, menopausal status and hormone use, hypercholesterolemia, hypertension, diabetes, family history
of MI, and individual- and area-level SES as appropriate. BMI indicates body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HRs, hazard ratios; MI, myocardial
infarction; PM, particulate matter; SES, socioeconomic status.
*P-for-interaction below our a level for statistical signiﬁcance of 0.0083.
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Table 7. HRs and 95% CI for a 10 lg/m3 Increase in 12-Month Average PM 2000–2006 With Risk of Incident CVD, CHD, or
Stroke, Stratiﬁed by Personal Characteristics
Outcome Cases Person-Years
PM10 PM2.5–10 PM2.5
Multivariable Multivariable Multivariable
Incident CVD
<70 years old 672 320 469 1.07 (0.93–1.24) 1.08 (0.89–1.32) 1.08 (0.82–1.42)
≥70 years old 1741 237 266 1.04 (0.94–1.14) 1.00 (0.87–1.15) 1.13 (0.95–1.34)
P-for-interaction 0.70 0.48 0.78
Women with diabetes 479 50 349 1.19 (1.02–1.39) 1.15 (0.94–1.40) 1.46 (1.06–2.01)
Women without diabetes 1934 507 392 1.00 (0.92–1.09) 0.98 (0.88–1.09) 1.05 (0.90–1.23)
P-for-interaction 0.05 0.17 0.07
Family history 972 179 039 1.01 (0.90–1.13) 0.97 (0.83–1.13) 1.09 (0.87–1.37)
No family history 1441 378 702 1.06 (0.96–1.16) 1.04 (0.92–1.17) 1.13 (0.94–1.36)
P-for-interaction 0.53 0.51 0.81
Underweight/normal 1008 229 716 1.03 (0.92–1.15) 0.98 (0.85–1.14) 1.16 (0.93–1.43)
Overweight 764 182 467 1.06 (0.94–1.21) 1.03 (0.87–1.22) 1.18 (0.92–1.52)
Obese 587 122 863 1.02 (0.88–1.19) 1.02 (0.84–1.25) 1.04 (0.78–1.40)
P-for-interaction 0.90 0.90 0.81
Never smokers 952 248 739 1.09 (0.98–1.22) 1.12 (0.98–1.29) 1.08 (0.87–1.35)
Former smokers 1119 248 456 1.04 (0.93–1.16) 0.97 (0.84–1.13) 1.23 (0.99–1.51)
Current smokers 340 59 419 0.83 (0.67–1.04) 0.76 (0.56–1.03) 0.91 (0.62–1.33)
P-for-interaction 0.10 0.05 0.38
Incident CHD
<70 years old 394 320 471 1.07 (0.88–1.31) 1.14 (0.88–1.48) 0.96 (0.66–1.39)
≥70 years old 907 237 270 1.00 (0.87–1.14) 0.95 (0.79–1.16) 1.09 (0.86–1.38)
P-for-interaction 0.53 0.22 0.57
Women with diabetes 309 50 349 1.09 (0.89–1.33) 1.03 (0.78–1.34) 1.31 (0.88–1.96)
Women without diabetes 992 507 392 0.96 (0.85–1.08) 0.94 (0.80–1.10) 0.99 (0.79–1.24)
P-for-interaction 0.29 0.57 0.23
Family history 552 179 039 1.02 (0.87–1.19) 0.95 (0.77–1.17) 1.21 (0.90–1.63)
No family history 749 378 702 0.97 (0.85–1.11) 0.97 (0.81–1.15) 0.96 (0.74–1.24)
P-for-interaction 0.62 0.89 0.24
Underweight/normal 496 229 716 0.98 (0.83–1.15) 0.97 (0.78–1.20) 0.99 (0.73–1.35)
Overweight 411 182 467 0.99 (0.83–1.19) 0.92 (0.73–1.18) 1.15 (0.81–1.62)
Obese 351 122 863 1.01 (0.83–1.23) 0.96 (0.74–1.26) 1.13 (0.77–1.65)
P-for-interaction 0.97 0.96 0.79
Never smokers 478 248 739 1.10 (0.94–1.28) 1.15 (0.95–1.40) 1.03 (0.75–1.42)
Former smokers 620 248 456 0.93 (0.79–1.08) 0.81 (0.66–1.01) 1.15 (0.86–1.52)
Current smokers 202 59 419 0.90 (0.68–1.19) 0.89 (0.61–1.28) 0.88 (0.53–1.45)
P-for-interaction 0.23 0.05 0.65
Incident stroke
<70 years old 300 320 471 1.08 (0.87–1.34) 1.02 (0.75–1.38) 1.27 (0.84–1.91)
≥70 years old 894 237 270 1.07 (0.94–1.22) 1.04 (0.86–1.25) 1.16 (0.92–1.47)
P-for-interaction 0.92 0.89 0.72
Continued
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mortality, with similar effect sizes for ischemic heart disease
and cerebrovascular mortality.16
Previously in the NHS, we observed suggestions of effect
modiﬁcation of our PM2.5 results by a number of cardiovas-
cular risk factors, although none of the modiﬁers reached
statistical signiﬁcance (deﬁned as P<0.05). In analyses of
PM2.5, higher HRs for total CHD were observed among women
with diabetes, those with a family history of MI, individuals
with hypercholesterolemia or hypertension, former and never
smokers, and the obese.15 A few recent long-term studies
have systematically assessed effect modiﬁcation to identify
susceptible subpopulations with mixed results. In both
ESCAPE analyses, no effect modiﬁcation was observed by
smoking status, BMI, or hypertension; diabetes was not
considered as an effect modiﬁer.7,8 Recent results from the
Agricultural Health Study showed elevated risks of CVD
mortality for increasing PM2.5 exposures only among male
participants.9 Effect modiﬁcation by BMI was observed, with
the highest risks among men with a BMI ≥26.5 kg/m2. In the
ACS, no statistically signiﬁcant effect modiﬁcation was
observed by baseline report of diabetes, hypertension or
existing heart disease.16 A recent review of effect modiﬁca-
tion in studies of the effects of short-term PM exposures
found strong evidence of effect modiﬁcation by age, with
higher risks among older individuals, weak or limited evidence
of effect modiﬁcation by sex and socioeconomic status, and
no effect modiﬁcation by race.17 Short-term studies have also
examined effect modiﬁcation by diabetes, and most have
suggested that individuals with diabetes are a susceptible
subpopulation.3,4,29–34 Therefore, although there is consistent
evidence that individuals with diabetes are particularly
vulnerable to the cardiovascular effects of acute exposures
to air pollution, our study is one of the ﬁrst to demonstrate
high risks of CVD among individuals with diabetes with long-
term exposures to PM.
Differences in susceptibility, especially among individuals
with diabetes, have also been reported in studies designed to
elucidate the biological mechanisms, typically inﬂammation,
underlying the adverse health effects of PM. The most
comparable studies, in terms of the populations studied and
the PM2.5 exposure averaging times used, have focused on the
effects of PM2.5 on C-reactive protein (CRP). In the longitudinal
Study of Women’s Health Across the Nation, associations
between PM2.5 averaged over the previous 12 months and CRP
were strongest among women with diabetes, with a 72.1%
increase (95% CI: 2.9 to 187.8) in CRP for each 10 lg/m3
increase in PM2.5 in the full study population and a 301%
increase (no conﬁdence interval provided) in CRP among the
oldest participants with diabetes (aged 50.5 to 55 years of age
at the start of the study).35 In the German Heinz Nixdorf Recall
Study, increases in annual average PM2.5 were associated with
increases in CRP in only male participants. However, each
Table 7. Continued
Outcome Cases Person-Years
PM10 PM2.5–10 PM2.5
Multivariable Multivariable Multivariable
Women with diabetes 194 50 349 1.31 (1.05–1.65) 1.29 (0.97–1.73) 1.64 (1.00–2.69)
Women without diabetes 1000 507 392 1.04 (0.93–1.16) 1.01 (0.87–1.17) 1.13 (0.91–1.40)
P-for-interaction 0.06 0.13 0.17
Family history 457 179 039 0.98 (0.83–1.16) 0.99 (0.79–1.23) 0.95 (0.68–1.32)
No family history 737 378 702 1.14 (1.01–1.29) 1.10 (0.93–1.29) 1.37 (1.07–1.76)
P-for-interaction 0.15 0.45 0.08
Underweight/normal 542 229 716 1.06 (0.92–1.23) 0.98 (0.80–1.19) 1.33 (1.00–1.78)
Overweight 387 182 467 1.15 (0.97–1.37) 1.15 (0.93–1.44) 1.24 (0.87–1.76)
Obese 254 122 863 1.02 (0.81–1.28) 1.06 (0.79–1.43) 0.93 (0.60–1.46)
P-for-interaction 0.66 0.54 0.42
Never smokers 494 248 739 1.10 (0.94–1.27) 1.10 (0.90–1.33) 1.16 (0.85–1.58)
Former smokers 549 248 456 1.15 (0.99–1.33) 1.12 (0.93–1.36) 1.32 (0.98–1.77)
Current smokers 150 59 419 0.75 (0.54–1.06) 0.62 (0.38–1.00) 0.93 (0.52–1.65)
P-for-interaction 0.08 0.07 0.55
Adjusted for age, time period, region, season, race, smoking status and pack-years, BMI, menopausal status and hormone use, hypercholesterolemia, hypertension, diabetes, family history
of MI, and individual- and area-level SES as appropriate. BMI indicates body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; HRs, hazard ratios; MI, myocardial
infarction; PM, particulate matter; SES, socioeconomic status.
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3.91 lg/m3 increase in PM2.5 was associated with an 82.6%
increase (95% CI: 1.1 to 230.3) in CRP among women with
diabetes, which was the largest increase observed among a
number of subgroups examined.36
Few studies have examined the impacts of different
exposure averaging windows. In our previous work in the
NHS, our ﬁndings for all size fractions were generally
consistent for exposure averaging times of 12 to 48
months.10,15 The HRs were most consistent in analyses of
PM10 and PM2.5 to 10. This is in contrast to our current ﬁndings
that show lower HRs for the 60- and 120-month exposure
averaging times compared to the 12- and 24-month averages.
However, the high correlations in exposures across time
windows make it difﬁcult to determine whether these
differences are solely due to chance or are related to true
differences in risk.
The limitations of this study should be noted. The NHS
predominantly comprises middle-aged and elderly white
women who at one time were nurses. Therefore, our results
may not be generalizable to men or to more racially or
socioeconomically diverse populations. Although we used a
sophisticated spatio-temporal model to estimate ambient PM
concentrations at the home addresses of each participant,
measurement error may still be present. We do not have
information on time-activity patterns, or housing characteris-
tics that may inﬂuence the inﬁltration of ambient PM.
Additionally, the lack of available monitoring information on
PM2.5 prior to 1999 and the need to estimate PM2.5 to 10
concentrations by subtraction for the full time period could
also lead to exposure misclassiﬁcation. Although we had time-
varying information on a number of confounders, residual
confounding is still always a concern even though validation
studies suggest accurate reporting in this group.37 The issue
of residual confounding is also raised by our observation of
confounding by socioeconomic status, both individual and
area level; our inability to control for small-scale spatial
autocorrelation; or spatial patterns in our selected con-
founders and effect modiﬁers, including the potentially strong
spatial patterns of diabetes prevalence in the United States.
This study also has notable strengths, including extensive
follow-up, a large number of well-validated cases of CVD, as
well as close to 20 years of monthly ambient PM predictions.
Compared to a number of studies with only mortality data, we
had the ability to examine incident cases. Finally, we have
time-varying information available on a variety of confounders
and effect modiﬁers of interest, which allowed us to evaluate
the importance of effect modiﬁcation independent of key
cardiovascular risk factors.
In conclusion, in this nationwide population of middle-aged
and older women, exposures to PM were associated with
small, but non–statistically signiﬁcant increases in the risk of
incident cardiovascular disease. This risk was elevated and
statistically signiﬁcant among women with diabetes. There
also were suggestions of effect modiﬁcation by age and
region; however, these were not consistent across PM size
fractions, time periods of follow-up, or outcomes. Overall, this
study adds to the literature on chronic exposures to air
pollution with cardiovascular outcomes, and adds to the
limited body of knowledge identifying especially susceptible
populations.
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